Energy News / Shareholders Foundation, Inc.

NASDAQ:EIDX Shareholder Notice: Investigation of Eidos Therapeutics, Inc. Concerning Possible Violations of Securities Laws

Via: ReleaseWire

Updated 11:45 AM CDT, Tue, April 16,2019

An investigation for investors in Eidos Therapeutics, Inc. (NASDAQ: EIDX) shares over potential securities laws violations by Eidos Therapeutics, Inc. was announced and NASDAQ: EIDX stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 04/16/2019 -- Eidos Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Eidos Therapeutics, Inc. (NASDAQ: EIDX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Eidos Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Francisco, CA based Eidos Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drugs to treat diseases caused by transthyretin (TTR) amyloidosis (ATTR). On April 1, 2019, after the market closed, Eidos Therapeutics, Inc filed a Form with the Securities and Exchange Commission ("SEC") announcing that its previously issued financial statements for the first three quarterly periods in the year ended December 31, 2018 could no longer be relied upon.

Shares of Eidos Therapeutics, Inc. (NASDAQ: EIDX) closed on April 8, 2019, at $23.74 per share.

Those who purchased shares of Eidos Therapeutics, Inc. (NASDAQ: EIDX) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqeidx-shareholder-notice-investigation-of-eidos-therapeutics-inc-concerning-possible-violations-of-securities-laws-1196725.htm

Media Relations Contact
Michael Daniels
858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com